http://www.fool.com/News/mft/2006/mft06090613.htm?ref=foolwatchCatalyst for ZymoGenetics?By Brian Lawler September 6, 2006 On Tuesday, after the market closed, biopharmaceutical company ZymoGenetics (Nasdaq: ZGEN) reported news that was good across the board: positive phase 3 trial results for its lead drug candidate, rhThrombin, used to control acute surgical bleeding........
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra